Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population
|
|
- Lesley Waters
- 6 years ago
- Views:
Transcription
1 3176 Nephrol Dial Transplant (2011) 26: doi: /ndt/gfr003 Advance Access publication 16 February 2011 Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population Jan A.J.G. van den Brand 1, Gerben A.J. van Boekel 1, Hans L. Willems 2, Lambertus A.L.M. Kiemeney 3, Martin den Heijer 3,4 and Jack F.M. Wetzels 1 1 Department of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 2 Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands, 3 Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Medical Centre, Nijmegen, The Netherlands and 4 Department of Endocrinology, Radboud University Medical Centre, Nijmegen, The Netherlands Correspondence and offprint requests to: Jan A.J.G. van den Brand; a.vandenbrand@nier.umcn.nl Abstract Background. Chronic kidney disease (CKD) is defined as the presence of kidney damage, albuminuria or a reduction in glomerular filtration rate (GFR). A GFR <60 ml/min/ 1.73m 2 alone is sufficient to diagnose CKD Stages III V. Recently, the new chronic kidney disease epidemiology collaboration (CKD-EPI) equation was introduced. It has been suggested to result in higher estimated glomerular filtration rates (egfrs) than the Modification of Diet in Renal Disease (MDRD 4 ) formula. Here, we assess consequences of introducing the CKD-EPI equation in a West European Caucasian population. Methods. Data were obtained from 6097 Caucasian participants of the Nijmegen Biomedical Study (2823 males and 3274 females). Serum creatinine values were determined using the Jaffe method, calibrated against mass spectrometry and Ó The Author Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please journals.permissions@oup.com
2 CKD-EPI and its effect on CKD prevalence 3177 were used to calculate egfr MDRD4 and egfr CKD-EPI.Demographic data, health status and information on medication use for all participants was obtained with a postal questionnaire. Results. The introduction of the CKD-EPI equation changed the curve of egfr by age, with higher values in the younger age groups and a steeper decline of egfr with ageing. As a consequence, younger people were more often classified to a higher GFR stage and older people, especially males, to a lower GFR stage. Conclusions. In comparison with the MDRD 4 formula, the CKD-EPI equation leads to higher estimates of GFR in young people and lower estimates in the elderly. On a population level, this may lead to higher estimates of kidney function. However, in routine clinical practice where the population is predominantly elderly, the opposite may be true. The introduction of egfr CKD-EPI necessitates reconsidering the definition of CKD. We suggest introducing age-dependent threshold values and/or the use of urinary albumin excretion to improve risk stratification. Keywords: chronic kidney disease; epidemiology; glomerular filtration rate Introduction According to the Kidney Disease Outcomes Quality Initiative, chronic kidney disease (CKD) is defined by the presence of kidney damage, albuminuria or a reduction of glomerular filtration rate (GFR) [1]. A reduced GFR, <60 ml/min/1.73m 2, is sufficient to diagnose CKD Stages III V. Thus, accurate estimation of GFR has become a heavily debated topic. The four variable equation developed in the Modification of Diet in Renal Disease (MDRD 4 ) Study is widely used in research and clinical practice. Its pros and cons and usefulness to define disease have been debated [2, 3]. The MDRD 4 formula may underestimate GFR in fairly young people and in women, thus overestimating the number of patients with CKD. GFR decreases with age and the risk associated with estimated glomerular filtration rate (egfr) values <60 ml/min/1.73m 2 is less evident in older people [4, 5]. This has led to a debate on the validity of using a cutoff value of 60 ml/min/1.73m 2 in elderly when defining CKD [2, 6]. Recently, the new CKD-EPI equation was developed [7]. Its mathematical properties allow for better estimation of measured GFR throughout its whole range, not just for values <60 ml/min/1.73m 2. However, this new equation was derived from a population consisting predominantly of young or middle-aged people with an average GFR of 70 ml/min/1.73m 2. It has been shown to result in higher estimates of GFR than the MDRD 4 formula and to provide a more appropriate risk classification in middle-aged individuals [8]. Little is known about the consequences of the introduction of the CKD-EPI equation for older people. The Nijmegen Biomedical Study is a population-based study with a sample stratified by age and gender. This allows for comparison of the MDRD 4 and CKD-EPI formulas across a wide range of ages. We assessed the consequences of introducing the CKD-EPI equation in our Caucasian population. Materials and methods Population Detailed methods of the Nijmegen Biomedical Study have been described elsewhere [5, 9]. In brief, the Nijmegen Biomedical Study is a populationbased cross-sectional survey conducted by the Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Age and sex stratified randomly selected adult inhabitants of the municipality of Nijmegen (Nijmegen, Lent and Oosterhout) were invited to fill out a postal questionnaire on lifestyle and medical history (n ¼ ). Overall, 9371 people (41.7%) filled out and returned the questionnaire. In total, 68.9% of the respondents donated two 8.5 ml tubes of blood (n ¼ 6455). Respondents were asked whether they had been diagnosed with myocardial infarction, stroke, diabetes, hypertension or any kidney disease. Information about drug therapy during the last 6 months was gathered. Respondents who were not diagnosed with nor used medication associated with aforementioned diseases were defined as healthy. Analysis was limited to 6097 Caucasian respondents with valid data of whom 2823 were males and 3274 females. Of this population, 2356 respondents reported an underlying condition or associated drug therapy. Estimation of GFR Serum creatinine was measured using a Jaffe alkaline picrate assay (Abbott Aeroset analyser) [5]. The Jaffe assay was calibrated to isotope diluted mass spectrometry (IDMS)-traceable creatinine values using the Roche enzymatic creatinine assay. The version of the MDRD 4 equation reexpressed for IDMS-traceable creatinine was used to calculate egfr MDRD4 [10]. The egfr CKD-EPI was calculated as described by Levey et al. [7]. egfr was expressed in millilitre per minute per 1.73 m 2. Statistical analysis Analyses were performed using Stata 10 software. We calculated means, SD range and 5th, 25th, 50th, 75th and 95th percentiles per 5-year age group in healthy participants. LMS Chart Maker version 2.4 (Medical Research Council, UK) was used to obtain smoothed egfr values for males and females. M (the smoothed median of egfr versus age), S (smoothed coefficient of variation of egfr versus age) and L (smoothed Box-Cox power transformation against age) curves were allowed additional degrees of freedom until no substantial change in chi-square statistic (<4.0) occurred [11]. We created crosstabs to evaluate classification of patients per GFR group according to both the CKD-EPI and MDRD 4 equations. Results We calculated egfr using CKD-EPI for 6097 Caucasian participants of the Nijmegen Biomedical Study. Study population characteristics are presented in Table 1. Figures 1 and 2 show that the curve of egfr versus age changes with the introduction of the egfr CKD-EPI. For young people, the median egfr value is higher. In women, >75 and men >70 years of age, median egfr values are lower when the CKD-EPI is used. Furthermore, the variance of egfr within our population appears to decrease when the CKD-EPI is used. Supplementary tables with egfr values by 5-year age group for the total and healthy population are available at the website (etables 1 and 2). The effect of the introduction of the CKD-EPI equation on egfr stratification is illustrated for men and women by age in Tables 2 and 3. To provide more detailed insight, we have tabulated egfr in classes of 15 ml/min/1.73m 2. The tables clearly illustrate that egfr is higher using the CKD- EPI formula. This effect is most prominent at higher levels
3 3178 J.A.J.G. van den Brand et al. Table 1. Population characteristics of the Nijmegen Biomedical Study a Healthy population Males Females Total population n (% males) % Age 53 (18 92) 48 (18 98) 58 (18 98) Medical history Myocardial infarction % Stroke % Hypertension % Kidney disease % Diabetes mellitus % Medication Drug therapy for CVD % Diuretics % Anti-hypertensives % Cholestrol-lowering drugs 34 2% 45 2% % Total number of drugs b 0 (0 13) 1 (0 20) 1 (0 50) Lifestyle Current smoker % % % Never smoked % % % Current alcohol use % % % Sedentary lifestyle % % % Laboratory Serum creatinine 79 (29 208) 65 (28 134) 73 (29 837) Serum urea 6.1 ( ) 5.1 (2 19.3) 5.8 (2 39.2) Serum albumin 46 (28 59) 45 (13 57) 45 (13 59) a Data are presented as n and percentage or median and (range), respectively. CVD, cardiovascular disease. b Including vitamin supplements. of egfr and in women. Importantly, and not unexpectedly, the effect on reclassification is dependent on age. When compared to the MDRD 4 formula, CKD-EPI gave higher estimates of GFR in subjects under the age of 70 but lower estimates in people >70 years. Discussion We compared values of egfr calculated with the recently developed CKD-EPI equation and the MDRD 4 formula using the data of the Nijmegen Biomedical Study, a sex- and age-stratified population-based survey. Our data demonstrate that the CKD-EPI formula overall provides higher estimates of GFR than the MDRD 4 formula. However, the differences are dependent on age and gender. Whereas in younger age groups, the CKD-EPI formula provides higher estimates of GFR, the opposite was true in older people, especially males. Our data indicate that the prevalence of young persons with egfr < 60 ml/min/1.73m 2 will decrease. In contrast, the number of elderly persons with egfr < 60 ml/min/1.73m 2 will increase. Development of a new formula to estimate GFR was stimulated by some shortcomings of the MDRD 4 equation, Fig. 1. Smoothed egfr by age for Caucasian males (total population) in the Nijmegen Biomedical Study. The interrupted lines represent the egfr CKD-EPI and the connected lines the egfr MDRD4. Data are presented as the p95, median and p5. Fig. 2. Smoothed egfr by age for Caucasian females (total population) in the Nijmegen Biomedical Study. The interrupted lines represent the egfr CKD-EPI and the connected lines the egfr MDRD4. Data are presented as the p95, median and p5.
4 CKD-EPI and its effect on CKD prevalence 3179 Table 2. Estimated GFR stage for Caucasian Dutch males over and under 70 years of age in the Nijmegen Biomedical Study population using the CKD-EPI or MDRD4 equation CKD-EPI MDRD egfr > <15 Total <70 years > < Total >70 years > < Total Table 3. egfr stage for Caucasian Dutch females over and under 70 years of age in the Nijmegen Biomedical Study population using the CKD-EPI or MDRD4 equation a CKD-EPI MDRD egfr > <15 Total >70 years > < Total >70 years > < Total a Blank cells have no observations. i.e. underestimation of egfr in women and healthy young white males and its lower accuracy at egfr > 60 ml/min/ 1.73m 2 [12]. Levey et al. [7] reported that the use of the CKD-EPI equation indeed resulted in higher egfrs especially in individuals with egfr > 60 ml/min/1.73m 2. At first glance, our data provide support for the introduction of the CKD-EPI equation in routine clinical practice. The CKD-EPI equation can be used in patients with egfr > 60 ml/min/1.73m 2. Moreover, the use of the CKD-EPI formula would decrease the estimated prevalence of CKD in the general population when a fixed threshold of 60 ml/min/1.73m 2 is used since the lower prevalence of egfr < 60 ml/min/1.73m 2 in young people will outweigh the higher prevalence in the elderly. A similar conclusion was drawn by White et al. [13]. In a population-based survey (AusDiab), the authors found that the estimated CKD prevalence dropped from 13.1 to 11.5% when the CKD-EPI was used. They reported that the CKD prevalence decreased particularly in women but remained high in the elderly. However, our conclusions, as those in the AusDiab study, hold for data derived from a study of the general population and may not apply to clinical practice. In routine clinical practice, measurements of serum creatinine are performed in elderly more often than in young people [14] Thus, it remains unknown if the number of people with egfr < 60 ml/min/1.73m 2 that come to the attention of healthcare officers really decreases. Moreover, there is
5 3180 J.A.J.G. van den Brand et al. already debate on the role of age in the use of egfr as a predictor of cardiovascular outcome. The decline of egfr with age is considered by some to be a part of normal ageing [2, 4]. In elderly persons, the association between egfr and adverse outcomes is attenuated, and an egfr value between 45 and 60 ml/min/1.73m 2 is not an independent risk factor for cardiovascular events in the elderly [14, 15]. Conversely, in persons under the age of 60 years egfr values >60 ml/min/1.73m 2 are independently predictive of outcome [16]. Inconsiderate introduction of the CKD-EPI equation might have unwanted effects and may not help to settle the debate. Our data indicate that the number of elderly persons with a diagnosis of CKD will increase, whereas a relevant reduction of egfr in young persons may go unnoticed. We suggest that with introduction of the CKD-EPI formula, the classification of CKD should be redefined. A solution may be to assess the decline in GFR not just its absolute level. A rapid decline (>3 ml/min/1.73m 2 / year) in egfr is associated with significantly increased risk of cardiovascular and all-cause mortality in elderly [17]. Obviously, the use of this parameter will make classification more cumbersome. Another option may be to include urinary protein excretion. Hemmelgarn et al. [18] showed that patients with severe proteinuria but without overtly abnormal egfr had worse clinical outcomes than those with moderately reduced egfr and no proteinuria. The authors suggest that risk stratification based on egfr alone is fairly insensitive to clinically relevant gradients in risk. Urinary albumin excretion is considered another powerful marker for risk of both cardiovascular and allcause mortality. A recent meta-analysis showed that a urinary albumin/creatinine ratio >10 mg/g is associated with increased all-cause and cardiovascular mortality [19]. These findings suggest that urinary albumin or protein excretion could be used to improve the classification of CKD. Finally, one might consider to use age-dependent egfr cut-off values. Our study has some weak points. To find out if the CKD- EPI equation is representative for the elderly population, one requires measured GFR in a sufficient number of people aged >70. Our population contains a fairly large number of subjects >70 but only estimated and not measured GFR. We used a questionnaire to ascertain the health status of participants. So subjects unaware of an underlying illness may incorrectly be classified as healthy. This is particularly relevant for people with asymptomatic chronic diseases such as diabetes mellitus. Finally, our population consisted of West European Caucasian subjects, so inferences to other populations should be made with caution. Conclusion In comparison with the MDRD 4 formula, the CKD-EPI equation leads to higher estimates of GFR in young people and lower estimates in the elderly. On a population level, this will lead to higher estimates of kidney function. In routine clinical practice, this effect may be less apparent. The introduction of egfr CKD-EPI necessitates the fine-tuning of the definition of CKD. We suggest either introducing age-dependent threshold values or the use of urinary protein or albumin excretion to improve risk stratification. Supplementary data Supplementary data is available online at oxfordjournals.org. Acknowledgements. J.F.M.W. and J.A.J.G.B. are supported by a grant of the Dutch kidney Foundation (NSN: OW08). We thank Dick Glassock for reading the manuscript and helpful comments. Conflict of interest statement. There were no financial or other interests. References 1. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for chronic kidney disease: evaluation classification, and stratification. Am J Kidney Dis 2002; 39: S1 S Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 2008; 23: Eknoyan G. Chronic kidney disease definition and classification: the quest for refinements. Kidney Int 2007; 72: O Hare AM, Choi AI, Bertenthal D et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007; 18: Wetzels JF, Kiemeney LA, Swinkels DW et al. Age- and genderspecific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 2007; 72: O Hare AM, Bertenthal D, Covinsky KE et al. Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 2006; 17: Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: Matsushita K, Selvin E, Bash LD et al. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2010; 55: Hoogendoorn EH, Hermus AR, de Vegt F et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006; 52: Wetzels JF, Willems HL, den Heijer M. Age- and gender-specific reference values of estimated glomerular filtration rate in a Caucasian population: Results of the Nijmegen Biomedical Study. Kidney Int 2008; 73: Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992; 11: Stevens LA, Coresh J, Feldman HI et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007; 18: White SL, Polkinghorne KR, Atkins RC et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the Aus- Diab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis 2010; 55: Raymond NT, Zehnder D, Smith SC et al. Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age. Nephrol Dial Transplant 2007; 22: Roderick PJ, Atkins RJ, Smeeth L et al. CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 2009; 53: van der Velde M, Bakker SJ, de Jong PE et al. Influence of age and measure of egfr on the association between renal function and cardiovascular events. Clin J Am Soc Nephrol 2010; 5:
6 CKD-EPI and its effect on CKD prevalence Shlipak MG, Katz R, Kestenbaum B et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 2009; 20: Hemmelgarn BR, Manns BJ, Lloyd A et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: Received for publication: ; Accepted in revised form:
Chapter 1: CKD in the General Population
Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table
More informationINDEX WORDS: Awareness; chronic kidney disease; Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI); estimated glomerular filtration rate.
KEEP 2010 Comparison of CKD Awareness in a Screening Population Using the Modification of Diet in Renal Disease (MDRD) Study and CKD Epidemiology Collaboration (CKD-EPI) Equations Manjula Kurella Tamura,
More informationA New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta
A New Approach for Evaluating Renal Function and Predicting Risk William McClellan, MD, MPH Emory University Atlanta Goals Understand the limitations and uses of creatinine based measures of kidney function
More informationConcept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA
Concept and General Objectives of the Conference: Prognosis Matters Andrew S. Levey, MD Tufts Medical Center Boston, MA General Objectives Topics to discuss What are the key outcomes of CKD? What progress
More informationChapter 2: Identification and Care of Patients With CKD
Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease
More informationEvaluation of Chronic Kidney Disease KDIGO. Paul E de Jong University Medical Center Groningen The Netherlands
Evaluation of Chronic Kidney Disease Paul E de Jong University Medical Center Groningen The Netherlands Evaluation and Management of CKD 1. Definition and classification of CKD 2. Definition and impact
More informationCreatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC
Creatinine & egfr A Clinical Perspective Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC CLINICAL CONDITIONS WHERE ASSESSMENT OF GFR IS IMPORTANT Stevens et al. J Am Soc Nephrol 20: 2305
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More informationTHE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS
214 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 21(3):23-212 doi: 1.2478/rjdnmd-214-25 THE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES
More informationNowadays it is often assumed that impaired renal function
Influence of Age and Measure of egfr on the Association between Renal Function and Cardiovascular Events Marije van der Velde, Stephan J.L. Bakker, Paul E. de Jong, and Ron T. Gansevoort Division of Nephrology,
More informationNice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care
Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care Paula D Souza Senior CKD Nurse Specialist Royal Devon and Exeter Healthcare Trust Introduction Background What
More informationAssessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation
Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation
More informationASSESSMENT OF A POINT-OF-CARE DEVICE FOR MEASURING CREATININE IN A COMMUNITY SCREENING PROGRAM FOR CHRONIC KIDNEY DISEASE
ASSESSMENT OF A POINT-OF-CARE DEVICE FOR MEASURING CREATININE IN A COMMUNITY SCREENING PROGRAM FOR CHRONIC KIDNEY DISEASE Brooke Ann Spaeth, Anne K Shephard, Mark DS Shephard, Timothy H Mathew ABSTRACT
More informationALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)
1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage
More informationSummary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup
http://www.kidney-international.org & 2013 DIGO Summary of Recommendation Statements idney International Supplements (2013) 3, 5 14; doi:10.1038/kisup.2012.77 Chapter 1: Definition and classification of
More informationChapter 2: Identification and Care of Patients With CKD
Chapter 2: Identification and Care of Patients With CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease
More informationComparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Comparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
More informationFull Review. Why overestimate or underestimate chronic kidney disease when correct estimation is possible?
Nephrol Dial Transplant (2017) 32: ii136 ii141 doi: 10.1093/ndt/gfw267 Full Review Why overestimate or underestimate chronic kidney disease when correct estimation is possible? Marc E. De Broe 1, Mohamed
More informationAn epidemic of chronic kidney disease: fact or fiction?
Nephrol Dial Transplant (2008) 23: 1117 1121 doi: 10.1093/ndt/gfn086 Debate on the epidemic of chronic kidney disease The Challenge An epidemic of chronic kidney disease: fact or fiction? Richard J. Glassock
More informationImpact of a single egfr and egfr-estimating equation on chronic kidney disease reclassification
Research Jennifer A Hirst, Maria DLA Vazquez Montes, Clare J Taylor, José M Ordóñez-Mena, Emma Ogburn, Vanshika Sharma, Brian Shine, Tim James and FD Richard Hobbs Impact of a single egfr and egfr-estimating
More informationSupplementary Online Content
Supplementary Online Content Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553-1559. eequation. Applying the
More informationMeasurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE
Measurement and Estimation of renal function Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE 1 2 How to estimate GFR? How to measure GFR? How to estimate GFR? How to measure GFR?
More informationChange in the estimated glomerular filtration rate over time and risk of all-cause mortality
clinical investigation http://www.kidney-international.org & 2013 International Society of Nephrology see commentary on page 550 Change in the estimated glomerular filtration rate over time and risk of
More informationChapter 2: Identification and Care of Patients with CKD
Chapter 2: Identification and Care of Patients with CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease
More informationDisclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationEpidemiology and prognostic significance of chronic kidney disease in the elderly the Three-City prospective cohort study.
Epidemiology and prognostic significance of chronic kidney disease in the elderly the Three-City prospective cohort study. Bénédicte Stengel, Marie Metzger, Marc Froissart, Muriel Rainfray, Claudine Berr,
More informationDisclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationClassification of CKD by Diagnosis
Classification of CKD by Diagnosis Diabetic Kidney Disease Glomerular diseases (autoimmune diseases, systemic infections, drugs, neoplasia) Vascular diseases (renal artery disease, hypertension, microangiopathy)
More informationThe relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan
Environ Health Prev Med (2011) 16:191 195 DOI 10.1007/s12199-010-0183-9 SHORT COMMUNICATION The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan Nobuyuki
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationChapter 2: Identification and Care of Patients With Chronic Kidney Disease
Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets
More informationPrimary Care Approach to Management of CKD
Primary Care Approach to Management of CKD This PowerPoint was developed through a collaboration between the National Kidney Foundation and ASCP. Copyright 2018 National Kidney Foundation and ASCP Low
More information23-Jun-15. Albuminuria Renal and Cardiovascular Consequences A history of progress since ,490,000. Kidney Center, UMC Groningen
Kidney function (egfr in ml/min) Albuminuria (mg/hr) Incidentie ESRD (%) 3-Jun- Number of patients worldwide that receives kidney replacement therapy Albuminuria Renal and Cardiovascular Consequences A
More informationSeung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine
Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine Age and Kidney Weight renal weight and thickening of the vascular intima Platt et al. Gerentology 1999;45:243-253
More informationCorrespondence should be addressed to Byung-Wan Lee; and Beom Seok Kim;
Hindawi Publishing Corporation International Journal of Endocrinology Volume 2013, Article ID 848963, 8 pages http://dx.doi.org/10.1155/2013/848963 Research Article Comparison of Two Creatinine-Based Equations
More informationPerformance of MDRD study and CKD-EPI equations for long-term follow-up of nondiabetic patients with chronic kidney disease
Nephrol Dial Transplant (2012) 27 (Supple 3): iii89 iii95 doi: 10.1093/ndt/gfr235 Advance Access publication 11 May 2011 Original Article Performance of MDRD study and CKD-EPI equations for long-term follow-up
More informationThere is a high prevalence of chronic kidney disease
CLINICAL INVESTIGATIONS Kidney Function and Mortality in Octogenarians: Cardiovascular Health Study All Stars Shani Shastri, MD, MPH, MS, a Ronit Katz, DPhil, b Dena E. Rifkin, MD, MS, c Linda F. Fried,
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationSeong Woo Lee 1, Yong Chul Kim 1, Se-Won Oh 2, Ho Seok Koo 1, Ki Young Na 2, Dong-Wan Chae 2, Suhnggwon Kim 1 and Ho Jun Chin 2.
Nephrol Dial Transplant (2011) 26: 3975 3980 doi: 10.1093/ndt/gfr154 Advance Access publication 31 March 2011 Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related
More informationNumerous epidemiologic studies have shown an association
SYMPOSIUM ARTICLE Cardiorenal Risk Factors Barry M. Wall, MD Abstract: The chronic renocardiac syndrome, in which chronic kidney disease (CKD) contributes to impairment of cardiac function or structure,
More informationCHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationISPUB.COM. J Reed III, N Kopyt INTRODUCTION METHODS AND MATERIALS
ISPUB.COM The Internet Journal of Nephrology Volume 6 Number 1 Prevalence of Albuminuria in the U.S. Adult Population Over the age of 40: Results from the National Health and Nutrition Examination Survey
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationoriginal article see commentary on page 1272
http://www.kidney-international.org & 0 International Society of Nephrology original article see commentary on page 7 Lower estimated glomerular filtration rate and higher albuminuria are associated with
More informationChronic kidney disease and life expectancy
Nephrol Dial Transplant (2012) 27: 3182 3186 doi: 10.1093/ndt/gfs052 Advance Access publication 22 March 2012 Chronic kidney disease and life expectancy Tanvir Chowdhury Turin 1, Marcello Tonelli 2, Braden
More informationAn unresolved issue: The relationship between spot urine protein-to-creatinine ratio and 24-hour proteinuria
Clinical Research Report An unresolved issue: The relationship between spot urine protein-to-creatinine ratio and 24-hour proteinuria Journal of International Medical Research 2019, Vol. 47(3) 1179 1184!
More informationCHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH SCIENTIFIC DIRECTOR KIDNEY HEALTH RESEARCH COLLABORATIVE - UCSF CHIEF - GENERAL INTERNAL MEDICINE, SAN FRANCISCO
More informationUWA Research Publication
UWA Research Publication Lim, W.H., Lewis, J.R., Wong, G., Dogra, G.K., Zhu, K., Lim, E.M., Dhaliwal, S.S. & Prince, R.L. (). Five-year decline in estimated glomerular filtration rate associated with a
More informationChronic Kidney Disease: Optimal and Coordinated Management
Chronic Kidney Disease: Optimal and Coordinated Management Michael Copland, MD, FRCPC Presented at University of British Columbia s 42nd Annual Post Graduate Review in Family Medicine Conference, Vancouver,
More informationTHE NKF-KDOQI (2002) CKD DEFINITION AND CLASSIFICATION SYSTEM: Limitations and Problems
THE NKF-KDOQI (2002) CKD DEFINITION AND CLASSIFICATION SYSTEM: Limitations and Problems Richard J. Glassock, MD, MACP David Geffen School of Medicine at UCLA KDIGO Controversies Conference London, UK October
More informationChapter 1: CKD in the General Population
Chapter 1: CKD in the General Population In light of the 2017 blood pressure guidelines from the American College of Cardiology/American Heart Association (ACC/AHA), this year we examine hypertension control
More informationRisk for chronic kidney disease increases with obesity: Health Survey for England 2010
Public Health Nutrition: 18(18), 3349 3354 doi:10.1017/s1368980015000488 Risk for chronic kidney disease increases with obesity: Health Survey for England 2010 Helen L MacLaughlin 1,2, *, Wendy L Hall
More informationOutline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationFrom Department of Medicine, David Geffen School of Medicine at UCLA.
FROM ISHIB 2009 THE PROS AND CONS OF STAGING CHRONIC KIDNEY DISEASE Background and Objectives: In 2002 the National Kidney Foundation Kidney Disease Outcomes Quality Initiative presented a new definition
More informationCreatinine (serum, plasma)
Creatinine (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Creatinine 1.2 Alternative names None 1.3 Description of analyte Creatinine is a heterocyclic nitrogenous compound (IUPAC
More informationCARDIO-RENAL SYNDROME
CARDIO-RENAL SYNDROME Luis M Ruilope Athens, October 216 DISCLOSURES: ADVISOR/SPEAKER for Astra-Zeneca, Bayer, BMS, Daiichi-Sankyo, Esteve, GSK Janssen, Lacer, Medtronic, MSD, Novartis, Pfizer, Relypsa,
More informationLife Science Journal 2014;11(10)
Performance of CKD-EPI versus MDRD among Diabetic Egyptians Khaled Abou-Seif, Yahya Makkeyah, Maha Behairy and Mohamed Mostafa Ali Internal Medicine & Nephrology Department, Ain Shams University Mahabehairy80@gmail.com
More informationIs the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?
Diabetes Care Publish Ahead of Print, published online October 3, 2008 The MCQ equation in DM2 patients Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration
More informationThe Impacts of Albuminuria and egfr on Cardiovascular Disease
American Journal of Health Research 2017; 5(4): 99-105 http://www.sciencepublishinggroup.com/j/ajhr doi: 10.11648/j.ajhr.20170504.12 ISSN: 2330-8788 (Print); ISSN: 2330-8796 (Online) The Impacts of Albuminuria
More informationRenal function vs chemotherapy dosing
Renal function vs chemotherapy dosing Jenny Casanova Senior Clinical Pharmacist Repatriation General Hospital Daw Park 1 Methods of estimating renal function Cockcroft-Gault (1976) C-G using ideal vs actual
More informationCystatin C versus Creatinine in Determining Risk Based on Kidney Function
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Cystatin C versus Creatinine in Determining Risk Based on Kidney Function Michael G. Shlipak, M.D., M.P.H., Kunihiro Matsushita, M.D.,
More informationCan modifications of the MDRD formula improve the estimation of glomerular filtration rate in renal allograft recipients?
Nephrol Dial Transplant (7) 22: 361 3615 doi:1.193/ndt/gfm282 Advance Access publication 22 September 7 Original Article Can modifications of the MDRD formula improve the estimation of glomerular filtration
More informationElevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC
Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007
More informationMeasurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE
Measurement and Estimation of renal function Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE 1 2 How to estimate GFR? How to measure GFR? How to estimate GFR? How to measure GFR?
More informationOnline clinical pathway for chronic kidney disease (CKD) in primary care. February 27, 2015 Dr. Kerry McBrien University of Calgary
Online clinical pathway for chronic kidney disease (CKD) in primary care February 27, 2015 Dr. Kerry McBrien University of Calgary FACULTY/PRESENTER DISCLOSURE Faculty: Kerry McBrien Relationships with
More informationManagement of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA
Management of New-Onset Proteinuria in the Ambulatory Care Setting Akinlolu Ojo, MD, PhD, MBA Urine dipstick results Negative Trace between 15 and 30 mg/dl 1+ between 30 and 100 mg/dl 2+ between 100 and
More informationCardiovascular and renal outcome in subjects with K/DOQI stage 1 3 chronic kidney disease: the importance of urinary albumin excretion
Nephrol Dial Transplant (2008) 23: 3851 3858 doi: 10.1093/ndt/gfn356 Advance Access publication 18 July 2008 Original Article Cardiovascular and renal outcome in subjects with K/DOQI stage 1 3 chronic
More informationCarboplatin Time to Drop the Curtain on the Dosing Debate
Carboplatin Time to Drop the Curtain on the Dosing Debate Jon Herrington, Pharm.D., BCPS, BCOP Judith Smith, Pharm.D., BCOP, CPHQ, FCCP, FISOPP Scott Soefje, Pharm.D., MBA, BCOP Heimberg J, et al. N Engl
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. 5. Classification of chronic kidney disease based on evaluation of kidney function
5. Classification of chronic kidney disease based on evaluation of kidney function Date written: April 2005 Final submission: May 2005 GUIDELINES No recommendations possible based on Level I or II evidence
More informationElevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age
Nephrol Dial Transplant (2007) 22: 3214 3220 doi:10.1093/ndt/gfm396 Advance Access publication 12 July 2007 Original Article Elevated relative mortality risk with mild-to-moderate chronic kidney disease
More information2017/3/7. Evaluation of GFR. Chronic Kidney Disease (CKD) Serum creatinine(scr) Learning Objectives
Evaluation of egfr and mgfr in CKD Use of CKD staging with case scenario Assessment of kidney function in CKD in adults Learning Objectives 台大雲林分院楊淑珍藥師 2017/03/11 Chronic Kidney Disease (CKD) Based on
More informationThe estimation of kidney function with different formulas in overall population
137 G E R I A T R I A 213; 7: 137-141 Akademia Medycyny ARTYKUŁ ORYGINALNY/ORIGINAL PAPER Otrzymano/Submitted: 28.8.213 Zaakceptowano/Accepted: 2.9.213 The estimation of kidney function with different
More informationUniversity of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste
University of Groningen Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish
More informationEvaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients
Original article Annals of Oncology 15: 291 295, 2004 DOI: 10.1093/annonc/mdh079 Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients G.
More informationAtherosclerosis 218 (2011) Contents lists available at ScienceDirect. Atherosclerosis
Atherosclerosis 218 (2011) 194 199 Contents lists available at ScienceDirect Atherosclerosis journa l h omepa g e: www.elsevier.com/locate/atherosclerosis The Chronic Kidney Disease Epidemiology Collaboration
More informationTREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009
TREAT THE KIDNEY TO SAVE THE HEART Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 1 ESRD Prevalent Rates in 1996 per million population December
More informationEstimates of glomerular filtration rate (GFR) from serum
Annals of Internal Medicine Review Estimating Equations for Glomerular Filtration Rate in the Era of Creatinine Standardization A Systematic Review Amy Earley, BS; Dana Miskulin, MD, MS; Edmund J. Lamb,
More informationThe National Quality Standards for Chronic Kidney Disease
The National Quality Standards for Chronic Kidney Disease Dr Robert Lewis Chief of Service, Wessex Kidney Centre, Portsmouth Specialist Committee Member Quality Standard for Chronic Kidney Disease, NICE
More informationSection Questions Answers
Section Questions Answers Guide to CKD Screening and Evaluation -Alec Otteman, MD Delaying Progression - Paul Drawz, MD, MHS, MS 1. Modifiable risk factors for CKD include: a. Diabetes b. Hypertension
More informationTitle:Impaired renal function and associated risk factors in newly diagnosed HIV-infected Adults in Gulu Hospital, Northern Uganda
Author's response to reviews Title:Impaired renal function and associated risk factors in newly diagnosed HIV-infected Adults in Gulu Hospital, Northern Uganda Authors: Pancras Odongo (odongopancras@gmail.com)
More informationDISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE
ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal
More informationE.Ritz Heidelberg (Germany)
Predictive capacity of renal function in cardiovascular disease E.Ritz Heidelberg (Germany) If a cure is not achieved, the kidneys will pass on the disease to the heart Huang Ti Nei Ching Su Wen The Yellow
More informationValidation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease
Kidney Diseases Validation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease Osama El Minshawy, 1 Eman El-Bassuoni 2 Original Paper 1 Department
More informationThe Association Between Cystatin C and Frailty Status in Older Men
The Association Between Cystatin C and Frailty Status in Older Men A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Allyson Hart IN PARTIAL FULFILLMENT OF THE
More informationEstimating GFR: From Physiology to Public Health. Outline of Presentation. Applications of GFR Estimations
stimating FR: From Physiology to Public Health Tufts: Andy Levey, Lesley (Stevens) Inker, Chris Schmid, Lucy Zhang, Hocine Tighiouart, Aghogho Okparavero, Cassandra Becker, Li Fan Hopkins: Josef Coresh,
More informationDepartment of Clinical Pathology, Faculty of Medicine Padjadjaran University-Dr. Hasan Sadikin General Hospital 2
Original Article Comparison of Estimated Glomerular Filtration Rate Mean Value of HARUS 15-30-60, HADI, and ASIAN Fomula Accuracy in Diabetes Mellitus Type 2 Sylvia Rachmayati, 1 Ida Parwati, 1 Abdul Hadi
More informationDefining risk factors associated with renal and cognitive dysfunction Joosten, Johanna Maria Helena
University of Groningen Defining risk factors associated with renal and cognitive dysfunction Joosten, Johanna Maria Helena IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationLaboratory Assessment of Diabetic Kidney Disease
Laboratory Assessment of Diabetic Kidney Disease Andrew S. Narva 1 and Rudolf W. Bilous 2 In Brief Regardless of etiology, chronic kidney disease (CKD) is identified by two laboratory tests: 1) estimated
More informationEstimating glomerular filtration rate in the general population: the second Health Survey of Nord-Trondelag (HUNT II)
Nephrol Dial Transplant (6) 21: 1525 1533 doi:1.193/ndt/gfl35 Advance Access publication 28 February 6 Original Article Estimating glomerular filtration rate in the general population: the second Health
More informationDemographic and clinical characteristics associated with glomerular filtration rates in living kidney donors
http://www.kidney-international.org & 2009 International Society of Nephrology see commentary on page 1 see on page 1071 Demographic and clinical characteristics associated with glomerular filtration rates
More informationResearch Article Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians
International Nephrology Volume 24, Article ID 746497, 8 pages http://dx.doi.org/.55/24/746497 Research Article Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation s in
More informationAGING KIDNEY IN HIV DISEASE
AGING KIDNEY IN HIV DISEASE Michael G. Shlipak, MD, MPH Professor of Medicine, Epidemiology and Biostatistics, UCSF Chief, General Internal Medicine, San Francisco VA Medical Center Kidney, Aging and HIV
More informationScreening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!
Screening for chronic kidney disease racial implications Not everybody that pees has healthy kidneys! Screening for chronic kidney disease racial implications 1) Definition of CKD 2) Why should we screen
More informationPage 1. Disclosures. Main Points of My Talk. Enlightened Views of Serum Creatinine, egfr, Measured GFR, and the Concept of Clearance
1 Enlightened Views of Serum Creatinine, egfr, Measured GFR, and the Concept of Clearance John Toffaletti, PhD Director of Blood Gas and Clinical Pediatric Laboratories Professor of Pathology Duke University
More informationSupplementary Online Content
Supplementary Online Content James MT, Neesh P, Hemmelgarn BR, et al. Derivation and external validation of prediction models for advanced chronic kidney disease following acute kidney injury. JAMA. doi:10.1001/jama.2017.16326
More informationIs CKD prevalence of 10-13% in Europe, US and China a realistic number or is there overdiagnosis of CKD? Marc E De Broe.
Is CKD prevalence of 10-13% in Europe, US and China a realistic number or is there overdiagnosis of CKD? Marc E De Broe November 2016 An example of partnership Maremar Maladies rénales au Maroc CKD IN
More informationCHRONIC KIDNEY DISEASE (CKD)
ORIGINAL CONTRIBUTION ONLINE FIRST Detection of Chronic Kidney Disease With,, and Urine Albumin-to- Ratio and Association With Progression to End-Stage Renal Disease and Mortality Carmen A. Peralta, MD,
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More informationThe evolution of renal function and the incidence of end-stage renal disease in patients aged 50 years
2297 Nephrol Dial Transplant (2012) 27: 2297 2303 doi: 10.1093/ndt/gfr659 Advance Access publication 18 November 2011 The evolution of renal function and the incidence of end-stage renal disease in patients
More information